|
    PRFX U.S.: Nasdaq

    PainReform Ltd.

    PRFXUS
    After Hours
    Last Updated: Sep 24, 2021 6:17 p.m. EDT Delayed quote

    $ 3.0400

    -0.01 -0.33%
    After Hours Volume: 115
    Close Chg Chg %
    $3.0500 0.1300 4.45%
    Advanced Charting
    Volume: 72.68K 65 Day Avg: 1.61M
    5% vs Avg
    2.9311 Day Range 3.0900
    2.1800 52 Week Range 7.8400

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    PRFX Overview

    Performance

    5 Day
    • -4.09%
    1 Month
    • 4.45%
    3 Month
    • 1.33%
    YTD
    • -31.77%
    1 Year
    • -40.58%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 1 Full Ratings

    Recent News

    PainReform Up 30% on Heavy Volume

    PainReform started at buy with $10 stock price target at Maxim Group

    PainReform sets IPO terms with plans to offer 2.55 million units priced at $8 to $10 each

    Maxim Group Sticks to Their Buy Rating for PainReform (PRFX)

    on TipRanks.com

    PainReform Ltd.

    PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.